Skip to content
10-Q

Quarterly Report

CHAMPIONS ONCOLOGY, INC. CSBR

0001628280-25-057082

← back to feed
Filed
Dec 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Dec 11, 2025 13.89M sh
Shares Diluted Q2 2026 · Oct 31, 2025 14.46M sh
Shares Diluted Q2 2026 · Oct 31, 2025 13.76M sh
Shares Diluted Q2 2026 · Oct 31, 2024 14.02M sh
Shares Diluted Q2 2026 · Oct 31, 2024 14.03M sh
Capex Q2 2026 · Oct 31, 2025 $288K
Capex Q2 2026 · Oct 31, 2024 $94K
Operating Cash Flow Q2 2026 · Oct 31, 2025 −$1.14M
Operating Cash Flow Q2 2026 · Oct 31, 2024 $28K
Cash And Equivalents Q2 2026 · Oct 31, 2025 $8.52M
Cash And Equivalents Q2 2026 · Apr 30, 2025 $9.79M
Stockholders Equity Q2 2026 · Oct 31, 2025 $4.17M
Stockholders Equity Q2 2026 · Apr 30, 2025 $3.77M
Current Liabilities Q2 2026 · Oct 31, 2025 $22.14M
Current Liabilities Q2 2026 · Apr 30, 2025 $23.85M
Total Liabilities Q2 2026 · Oct 31, 2025 $25.93M
Total Liabilities Q2 2026 · Apr 30, 2025 $28.57M
Current Assets Q2 2026 · Oct 31, 2025 $21.33M
Current Assets Q2 2026 · Apr 30, 2025 $22.36M
Total Assets Q2 2026 · Oct 31, 2025 $30.16M
Total Assets Q2 2026 · Apr 30, 2025 $32.34M
Eps Diluted Q2 2026 · Oct 31, 2025 $0.02
Eps Diluted Q2 2026 · Oct 31, 2025 −$0.01
Eps Diluted Q2 2026 · Oct 31, 2024 $0.05
Eps Diluted Q2 2026 · Oct 31, 2024 $0.15
Eps Basic Q2 2026 · Oct 31, 2025 $0.02
Eps Basic Q2 2026 · Oct 31, 2025 −$0.01
Eps Basic Q2 2026 · Oct 31, 2024 $0.05
Eps Basic Q2 2026 · Oct 31, 2024 $0.15
Sga Expense Q2 2026 · Oct 31, 2025 $2.97M
Sga Expense Q2 2026 · Oct 31, 2025 $5.54M
Sga Expense Q2 2026 · Oct 31, 2024 $1.89M
Sga Expense Q2 2026 · Oct 31, 2024 $4.42M
Rd Expense Q2 2026 · Oct 31, 2025 $2.62M
Rd Expense Q2 2026 · Oct 31, 2025 $4.7M
Rd Expense Q2 2026 · Oct 31, 2024 $1.69M
Rd Expense Q2 2026 · Oct 31, 2024 $3.14M
Net Income Q2 2026 · Oct 31, 2025 $268K
Net Income Q2 2026 · Oct 31, 2025 −$169K
Net Income Q2 2026 · Oct 31, 2024 $728K
Net Income Q2 2026 · Oct 31, 2024 $2.04M
Operating Income Q2 2026 · Oct 31, 2025 $185K
Operating Income Q2 2026 · Oct 31, 2025 −$342K
Operating Income Q2 2026 · Oct 31, 2024 $732K
Operating Income Q2 2026 · Oct 31, 2024 $2.06M
Cost Of Revenue Q2 2026 · Oct 31, 2025 $7.26M
Cost Of Revenue Q2 2026 · Oct 31, 2025 $15.26M
Cost Of Revenue Q2 2026 · Oct 31, 2024 $7.43M
Cost Of Revenue Q2 2026 · Oct 31, 2024 $14.5M
Revenue Q2 2026 · Oct 31, 2025 $15.04M
Revenue Q2 2026 · Oct 31, 2025 $29.03M
Revenue Q2 2026 · Oct 31, 2024 $13.49M
Revenue Q2 2026 · Oct 31, 2024 $27.55M